查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1304503

全球營養保健品配料市場 - 2023-2030

Global Nutraceutical Ingredients Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

2022年，全球營養保健品配料市場規模達到1745億美元，預計到2030年將達到3275億美元，實現利潤豐厚的成長。在預測期內（2023-2030年），全球營養保健品配料市場預計將呈現8.4%的複合年成長率。

營養保健品具有多種益處，包括改善健康狀況、延緩衰老、預防慢性疾病、延長預期壽命以及支持身體結構和功能。它們還可用於預防和治療精神健康問題和疾病。保健食品成分可作為膳食補充劑廣泛獲取，因此很容易涵蓋人們的日常生活。它們為那些可能無法僅從飲食中獲得足夠營養的人們提供了一種簡單的解決方案。

市場動態

慢性病發病率上升

糖尿病、高血壓、癌症等慢性病發病率的上升將推動市場的成長。慢性疾病，尤其是肥胖症和糖尿病，是老年人的主要擔憂。例如，全球糖尿病患病率的上升推動了市場的擴張。根據國際糖尿病聯合會的數據，到2021年，約有5370億人患有糖尿病，佔全球每10人中的1人。

預計到2030年將達到6430億，到2045年將達到7830億。此外，每四個糖尿病患者中就有三個生活在中低收入國家。 2021年，每5秒鐘就有1人死於糖尿病，全球死亡人數將近67億。預計2021年糖尿病醫療支出將超過9660億美元，比前15年成長316%。因此，疾病的增加將有助於推動市場成長。

強化食品的增加

強化食品的增加是預測期內市場成長的主要驅動力之一。例如，根據澳大利亞政府組織CSIRO（聯邦科學與工業研究組織）的預測，到2030年，強化食品和功能性食品的需求將達到97億美元，年成長率約為3%。隨著世界人口的持續成長和消費者偏好的轉變，市場對強化食品和功能性食品的需求預計將保持強勁。

該行業的特點是產品結構多樣化，從老年消化系統和心血管健康膳食到新生兒和幼兒成長食品，應有盡有。預計到2030年，強化食品和功能性食品的國內市場規模將達到55億美元，出口機會為42億美元。

營養保健品原料成本高昂

營養保健品配料應用廣泛，包括動物營養品、藥品、功能性食品和飲料以及個人護理用品。另一方面，在藥品、飼料產品、食品和飲料以及個人護理用品中添加營養保健品成分會提高最終產品的價格。最終產品的價格上漲阻礙了行業的發展，因為大多數消費者都避免購買昂貴的食品，而選擇天然食品。

COVID-19影響分析

COVID-19大流行對全球保健品配料業務產生了負面影響。疫情擾亂了原料供應鏈，導致短缺和價格變動。生產設施的關閉和運輸限制也導致市場成長大幅下降。疫情引發的經濟衰退降低了消費者的消費能力，導致對高價營養保健品成分的需求下降。

俄烏戰爭影響分析

據估計，俄烏衝突對全球保健品原料市場的影響不大，因為該地區的主要市場參與者較少。然而，在預測期內，營養保健品進出口對全球營養保健品成分市場成長的影響預計不大。

目錄

第一章研究方法和範圍

  • 研究方法
  • 研究目的和報告範圍

第2章：定義和概述

第三章：執行摘要

  • 按產品類型分類的市場摘要
  • 按形態分類的市場摘要
  • 按健康益處分類的市場片段
  • 按應用市場分類
  • 按地區分類的市場摘要

第四章：市場動態

  • 影響因素
    • 驅動因素慢性疾病發病率增加
    • 強化食品的增加
  • 限制因素
    • 營養保健品原料成本高
  • 機會
    • 營養保健品配料行業的創新
  • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 法規分析

第六章：COVID-19分析

  • COVID-19分析
    • COVID-19之前的情況
    • COVID-19期間的情景
    • COVID-19之後的情景
  • COVID-19期間的定價動態
  • 供求關係
  • 大流行期間與市場相關的政府計劃
  • 製造商的戰略計劃
  • 結論

第七章：按產品類型

  • 益生菌
  • 蛋白質和氨基酸
  • 植物化學物和植物提取物
  • 纖維和特殊碳水化合物
  • 歐米伽-3脂肪酸
  • 維生素
  • 益生元
  • 類胡蘿蔔素
  • 礦物質
  • 其他

第八章：按形態分類

  • 幹
  • 液體

第九章：按健康益處分類

  • 認知健康
  • 腸道健康
  • 心臟健康
  • 骨骼健康
  • 免疫
  • 營養
  • 體重管理
  • 其他

第10章：按應用分類

  • 食品
    • 零食
    • 糖果
    • 烘焙食品
    • 乳製品
    • 肉類及肉製品
    • 嬰兒食品
    • 其他食品
  • 飲料
    • 能量飲料
    • 果汁飲料
    • 健康飲料
    • 個人護理
    • 動物營養
    • 膳食補充劑

第十一章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 日本
    • 日本
      • 亞太其它地區
  • 中東和非洲
    • 主要地區動態

第十二章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併與收購分析

第十三章：公司簡介

  • Associated British Foods
    • 公司概況
    • 產品組合和描述
    • 財務概況
    • 主要發展
  • Arla Foods
  • DSM
  • Ingredients
  • Tate & Lyle
  • Ajinomoto
  • CHR. Hansen
  • Kyowa Hakko Kirin Group
  • Glanbia Plc
  • Fonterra Co-Operative Group Limited

第十四章：附錄

簡介目錄
Product Code: FB418

Market Overview

The Global Nutraceutical Ingredients Market reached US$ 174.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 327.5 billion by 2030. the global nutraceutical ingredients market is expected to exhibit a CAGR of 8.4% during the forecast period (2023-2030).

Nutraceuticals provide multiple benefits, including improved health, slowed ageing, prevention of chronic illnesses, increased life expectancy, and support of the body's structure and functioning. They are also used to prevent and treat mental health concerns and illnesses. Nutraceutical ingredients are widely accessible as dietary supplements, making them easy to include into one's everyday routine. They offer a simple solution for folks who may not get enough nutrients from their diet alone.

Market Dynamics

Increase in Incidence of Chronic Diseases

The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, and others would propel the market's growth rate. Chronic diseases, particularly obesity and diabetes, are a major source of concern among the elderly. For instance, the rising prevalence of diabetes around the world is driving market expansion. According to the International Diabetes Federation, approximately 537 Billion individuals will have diabetes by 2021, accounting for one out of every ten people worldwide.

It is expected to reach 643 Billion by 2030, and 783 Billion by 2045. Furthermore, three out of every four persons with diabetes live in low- and middle-income nations. Diabetes claimed one life every five seconds in 2021, accounting for nearly 6.7 Billion fatalities worldwide. Diabetes healthcare spending in 2021 is expected to be over $ 966 billion, representing a 316% increase over the previous 15 years. Thus rise of diseases will helps drive the market growth.

Rise in Fortified Foods

Rise in fortified foods is one of the key driver that helps the market to grow during forecast period. For instance, according to the CSIRO (Commonwealth Scientific and Industrial Research Organisation), an Australian government organisation, demand for fortified and functional foods is predicted to reach $9.7 billion by 2030, with an annual growth rate of roughly 3%. With the world's population continuing to grow and consumer preferences shifting, market demand for fortified and functional foods is expected to stay robust.

The industry is distinguished by a diverse product mix that includes everything from meals for old digestive and cardiovascular health to foods for newborn and toddler growth. The domestic market for fortified and functional goods is estimated to reach $5.5 billion by 2030, with an opportunity for exports of $4.2 billion.

High Cost of Nutraceutical Ingredients

Nutraceutical ingredients are employed in a variety of applications, including animal nutrition, medicines, functional food and drinks, and personal care items. The incorporation of nutraceutical ingredients in medicines, feed products, food and beverage goods, and personal care items, on the other hand, raises the final product price. The increasing expense of the end products stifles industry expansion since most customers avoid purchasing expensive food items in favour of natural ones.

COVID-19 Impact Analysis

The pandemic of COVID-19 has a negative impact on the worldwide nutraceutical ingredients business. The epidemic disrupted the raw material supply chain, resulting in shortages and price changes. Closures of production facilities and transportation limitations also contributed to a major reduction in market growth. The pandemic-caused economic downturn lowered consumer spending power, resulting in lower demand for high-priced nutraceutical components.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global nutraceutical ingredients market, owing to the low number of key market players in this region. However, the impact of the import and export of nutraceutical is expected to have little influence over the global nutraceutical ingredients market growth over the forecast period.

Segment Analysis

The global nutraceutical ingredients market is segmented based on product type , form, health benefits, application and region.

Proteins Product Type Segment Accounts for 32.9 % of Market Share.

Probiotics product type segment with around 32.9% is expected to dominate during the forecast period. Proteins are critical macronutrients that aid in tissue growth and repair, muscle mass maintenance, and immune system support. As a result, they are in great demand for the manufacture of nutritional supplements and functional foods.

Since, the rising incidence of lifestyle disorders such as obesity, diabetes, and cardiovascular disease has increased demand for protein-based nutraceutical products, which are recognised to aid in weight reduction, blood sugar regulation, and cardiovascular health. Plant-based protein sources such as soy, pea, and rice protein are in high demand due to the rising popularity of plant-based and vegan diets.

Furthermore, technical improvements in protein extraction and isolation techniques have made it possible to create high-quality protein components at a cheaper cost, driving the protein section of the nutraceutical ingredients market forward.

Geographical Analysis

North America Accounted for Approximately 38.4% of the Market Share 2022

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period. North America is predicted to have good market growth since customers are willing to pay a premium for healthier items due to their increased income and buying power. With increased health and fitness concerns, there is a growing consumption of nutraceutical ingredients loaded nutritious meals. In online retail establishments, nutraceutical ingredients enriched with nutritious meals are widely available. The rapid expansion of functional beverages will drive market growth.

Competitive Landscape

The major global players in the nutraceutical ingredients market include: Associated British Foods, Arla Foods, DSM, Ingredients, Tate & Lyle, Ajinomoto, CHR. Hansen, Kyowa Hakko Kirin Group, Glanbia Plc, and Fonterra Co-Operative Group Limited.

Why Purchase the Report?

  • To visualize the global nutraceutical ingredients market segmentation based on product type, form, health benefits, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of nutraceutical ingredients market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global nutraceutical ingredients market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Product Type
  • 3.2. Market Snippet By Form
  • 3.3. Market Snippet By Health Benefits
  • 3.4. Market Snippet By Application
  • 3.5. Market Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. DriversIncrease in Incidences of Chronic Diseases
    • 4.1.2. Rise in Fortified Foods
  • 4.2. Restraints
    • 4.2.1. High Cost of Nutraceutical Ingredients
  • 4.3. Opportunity
    • 4.3.1. Innovations in Nutraceutical Ingredients Industry
  • 4.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Probiotics *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Proteins and Amino Acids
  • 7.4. Phytochemical & Plant Extracts
  • 7.5. Fibers & Specialty Carbohydrates
  • 7.6. Omega-3 Fatty Acids
  • 7.7. Vitamins
  • 7.8. Prebiotic
  • 7.9. Carotenoids
  • 7.10. Minerals
  • 7.11. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Dry *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Liquid

9. By Health Benefits

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 9.1.2. Market Attractiveness Index, By Health Benefits
  • 9.2. Cognitive Health *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Gut Health
  • 9.4. Heart Health
  • 9.5. Bone Health
  • 9.6. Immunity
  • 9.7. Nutrition
  • 9.8. Weight Management
  • 9.9. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Food *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 10.2.3. Snacks
    • 10.2.4. Confectionery
    • 10.2.5. Bakery
    • 10.2.6. Dairy
    • 10.2.7. Meat & Meat Products
    • 10.2.8. Baby Food
    • 10.2.9. Others
  • 10.3. Beverages
    • 10.3.1. Energy Drinks
    • 10.3.2. Juices
    • 10.3.3. Health Drinks
    • 10.3.4. Personal Care
    • 10.3.5. Animal Nutrition
    • 10.3.6. Dietary Supplement

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Associated British Foods *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Arla Foods
  • 13.3. DSM
  • 13.4. Ingredients
  • 13.5. Tate & Lyle
  • 13.6. Ajinomoto
  • 13.7. CHR. Hansen
  • 13.8. Kyowa Hakko Kirin Group
  • 13.9. Glanbia Plc
  • 13.10. Fonterra Co-Operative Group Limited

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us